HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages OrthoPediatrics (KIDS) Investors to Contact Its Attorneys Now, Firm Investigating Possible Securities Fraud

SAN FRANCISCO, Dec. 4, 2020 /PRNewswire/ — Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now. …

SAN FRANCISCO, Dec. 4, 2020 /PRNewswire/ — Hagens Berman urges OrthoPediatrics Corp. (NASDAQ: KIDS) investors to submit their losses now.  The firm is investigating possible securities law violations.

Visit: www.hbsslaw.com/investor-fraud/KIDS  

Contact An Attorney Now: KIDS@hbsslaw.com   


OrthoPediatrics Corp. (KIDS) Investigation:

The investigation centers on whether OrthoPediatrics artificially inflated reported revenues by engaging in an illegal channel stuffing scheme.

In past quarters, OrthoPediatrics touted its «consistent 20% plus growth rate,» which in turn has allowed the Company to maintain a valuation at 11 times annual revenues.  In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors «when products are used in procedures.»

But on Dec. 2, 2020, the veracity of OrthoPediatrics’ growth story came into question when Culper Research published a scathing report.

Based on interviews with OrthoPediatrics distributors and former executives, Culper concludes: (1) OrthoPediatrics «has engaged in a channel stuffing scheme that has systematically and significantly overstated revenues,» (2) «[w]e believe that the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company,» and (3) «distributors have been induced to buy excess product directly from the Company in exchange for (a) equity-based awards, (b) the opportunity to return product, and/or (c) product discounts or increased commission schedules.»

This news drove the price of OrthoPediatrics shares crashing lower.

«We’re focused on investor losses and whether OrthoPediatrics engaged in revenue recognition fraud,» said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you are an OrthoPediatrics investor, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding OrthoPediatrics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 844-916-0895 or email KIDS@hbsslaw.com.

About Hagens Berman

Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.


Reed Kathrein, 844-916-0895


Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hagens-berman-national-trial-attorneys-encourages-orthopediatrics-kids-investors-to-contact-its-attorneys-now-firm-investigating-possible-securities-fraud-301186757.html

SOURCE Hagens Berman Sobol Shapiro LLP